BE900749A - Medicament microencapsule dans une matrice sucree. - Google Patents

Medicament microencapsule dans une matrice sucree.

Info

Publication number
BE900749A
BE900749A BE0/213776A BE213776A BE900749A BE 900749 A BE900749 A BE 900749A BE 0/213776 A BE0/213776 A BE 0/213776A BE 213776 A BE213776 A BE 213776A BE 900749 A BE900749 A BE 900749A
Authority
BE
Belgium
Prior art keywords
medicament
microencapsule
drug
sweet
matrix
Prior art date
Application number
BE0/213776A
Other languages
English (en)
French (fr)
Original Assignee
Rotman Avner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotman Avner filed Critical Rotman Avner
Publication of BE900749A publication Critical patent/BE900749A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/213776A 1983-10-03 1984-10-03 Medicament microencapsule dans une matrice sucree. BE900749A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53880183A 1983-10-03 1983-10-03

Publications (1)

Publication Number Publication Date
BE900749A true BE900749A (fr) 1985-02-01

Family

ID=24148464

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213776A BE900749A (fr) 1983-10-03 1984-10-03 Medicament microencapsule dans une matrice sucree.

Country Status (14)

Country Link
JP (1) JPS60105612A (da)
AU (1) AU3379984A (da)
BE (1) BE900749A (da)
CA (1) CA1239585A (da)
CH (1) CH661663A5 (da)
DE (1) DE3435747A1 (da)
DK (1) DK472584A (da)
FR (1) FR2552665B1 (da)
GB (1) GB2147501B (da)
IL (1) IL73157A (da)
IT (1) IT1178019B (da)
NL (1) NL8403003A (da)
SE (1) SE8404808L (da)
ZA (1) ZA847743B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937076A (en) * 1984-08-10 1990-06-26 Combe Incorporated Chewable aspirin and buffering material tablet and method for producing same
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
GR1001437B (el) * 1992-11-05 1993-12-30 Aggelos Kontos Ζαχαροπλαστικό σύστημα χορηγήσεως φαρμακολογικώς δραστικών ουσιών.
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
WO1998024410A2 (en) * 1996-12-03 1998-06-11 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
DE69934505T2 (de) * 1998-05-18 2007-10-04 Takeda Pharmaceutical Co. Ltd. Im munde zerfallende tablette enthaltend ein benzimidazole
TW585786B (en) 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
SE0103210D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
US7371405B2 (en) 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms
CA2790097A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
MX378262B (es) 2015-03-31 2025-03-10 Laboratorios Bago S A Procedimiento de elaboración de pellets entéricos que contienen un inhibidor de la bomba protónica y composiciones farmacéuticas multiparticuladas que los contienen.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB490001A (en) * 1936-12-03 1938-08-02 Atlantic Coast Fisheries Co Improvements in or relating to a vitamin product
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3697641A (en) * 1970-01-02 1972-10-10 Gerhard W Ahrens Nonhygroscopic non-sugarbase noncariogenic-vitamin c releasable base material for use in the preparation of suckable tablets,lozenges and chocolate
CH519858A (fr) * 1971-05-04 1972-03-15 Interfood S A Procédé de préparation de denrées alimentaires thermo-résistantes à base de matières grasses
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule
DE2347713C3 (de) * 1972-09-25 1980-03-06 Warner-Lambert Co., Morris Plains, N.J. (V.St.A.) Acetylsalicylsäurekautablette
US4288460A (en) * 1979-05-24 1981-09-08 Balchem Corporation Non-caking, water-soluble, granular coated food ingredient
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
GB2075818B (en) * 1980-05-21 1984-09-05 Farm Feed Holdings Ltd Torrefied cereals for use in the feeding and veterinary treatment of ruminant animals
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
DE3278491D1 (en) * 1981-07-15 1988-06-23 Key Pharma Sustained release theophyline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix

Also Published As

Publication number Publication date
IL73157A0 (en) 1985-01-31
FR2552665A1 (fr) 1985-04-05
CH661663A5 (de) 1987-08-14
GB2147501A (en) 1985-05-15
AU3379984A (en) 1985-04-18
DE3435747A1 (de) 1985-04-11
IL73157A (en) 1988-10-31
SE8404808L (sv) 1985-04-04
GB2147501B (en) 1988-01-27
DK472584D0 (da) 1984-10-02
IT1178019B (it) 1987-09-03
SE8404808D0 (sv) 1984-09-26
IT8448945A0 (it) 1984-10-03
GB8424833D0 (en) 1984-11-07
FR2552665B1 (fr) 1988-09-09
DK472584A (da) 1985-04-04
ZA847743B (en) 1985-06-26
NL8403003A (nl) 1985-05-01
JPS60105612A (ja) 1985-06-11
IT8448945A1 (it) 1986-04-03
CA1239585A (en) 1988-07-26

Similar Documents

Publication Publication Date Title
BE900749A (fr) Medicament microencapsule dans une matrice sucree.
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
DE60127379D1 (de) Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung
NO912001L (no) Buccal tablett med hurtig utlevering.
DZ1078A1 (fr) Formulation pharmaceutiques de substance labiles aux acides pour administration orale.
EP1161956A4 (en) DRUG COMPOSITIONS
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
ATE252892T1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
FR2712807B1 (fr) Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US4876283A (en) Antisnoring agent
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
EP1365749A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
US5702723A (en) Multi-stage delivery system for ingestible medications or nutrients
WO2002092067A1 (en) Compositions for transmucosal administration containing coenzyme q as the active ingredient
EP0390832A1 (fr) Medicament comprenant l'association de colistine, de tobramycine et d'amphotericine b administree par vaporisation
EP0271151A3 (en) Azumolene dosage form
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
KR890003386A (ko) 항 고지방 혈증제
US20060062811A1 (en) Medicinal cooling emulsions
EA199900938A1 (ru) Способ приготовления стабильного фармацевтического состава с фиксированной дозировкой из антиинфекционного агента/агентов и микроорганизмов в качестве активных ингредиентов
US2465233A (en) Motion sickness chewing gum
KR0129409B1 (ko) 츄잉 연질정제의 제조방법
KR930017579A (ko) 신경 보호제
FR2750859B1 (fr) Composition pharmaceutique destinee a une administration par voie buccale avec absorption d'au moins un principe actif a travers les muqueuses de la bouche

Legal Events

Date Code Title Description
CH Change of patent owner

Owner name: *BIO-DAR LTD

Effective date: 19841003

RE Patent lapsed

Owner name: BIO-DAR LTD

Effective date: 20001031